Title: Tapentadol vs tramadol in pain control and tolerability of head and neck carcinoma patients
Authors: Dr. P.N. Sathiyamoorthy, Dr N. Rajesh Kar, Karthikeyan Perumal
DOI: https://dx.doi.org/10.18535/jmscr/v7i5.30
Abstract
Introduction
Pain is the major symptom in carcinoma patients to control, in head and neck carcinoma pain contributes to decreased appetite and malnourishment and dehydration, hence control of pain is a challenge and helps to improve performance and quality of life of carcinoma patients.
Aim
The aim of the study was to assess the pain control and tolerability between tapentadol and tramadol in head and neck carcinoma patients
References
- Singh DR, Nag K, Sheti AN, Krishnaveni N. Tapentadol hydrochloride: A novel analgesic. Saudi J Anaesth 2013;7:322-6.
- Cohen MJ, Schecter WP. Perioperative pain control: A strategy for management. Surg Clin North Am 2005;85:1243-57.
- Banerjee M, Bhaumik DJ, Ghosh AK. A comparative study of oral tramadol and ibuprofen in postoperative pain in operations of lower abdomen. J Indian Med Assoc 2011;109:619-22, 626.
- Mishra H, Khan FA. A double-blind, placebo-controlled randomized comparison of pre and postoperative administration of ketorolac and tramadol for dental extraction pain. J Anaesthesiol Clin Pharmacol 2012;28:221-5.
- Joshi S, Jagadeesh AM. Efficacy of perioperative pregabalin in acute and chronic postoperative pain after off pump coronary artery bypass - A random double blind placebo controlled trial. Ann Card Anaesth 2013.
- Ross MA, Hemphill RR, Abramson J, et al. The recidivism characteristics of an emergency department observation unit. Ann Emerg Med 2010;56:34–41.
- Vázquez Quiroga B, Pardo Moreno G, Fernández Cantalejo G, et al. Why do our patients go to hospital emergency departments? Aten Primaria 2000;25:172–5.
- Tudela P, Mòdol JM. Hospital emergency rooms. Med Clin (Barc) 2003;120:711–6.
- Guillén Astete C, Kaumi L, Tejada Sorados RM, et al. Prevalence of non-traumatic musculoskeletal pathology as main complaint and its impact in an emergency department. Semergen 2016;42:158–63.
- Fialho SC, de Castro GR, Zimmermann AF, et al. Musculoskeletal system assessment in an emergency room. Rev Bras Reumatol 2011;51:240–8.
- Hoy D, Bain C, Williams G, et al. A systematic review of the global prevalence of low back pain. Arthritis Rheum 2012;64:2028–37.
- Friedman BW, Chilstrom M, Bijur PE, et al. Diagnostic testing and treatment of low back pain in United States emergency departments: a national perspective. Spine (Phila Pa 1976) 2010;35:E1406–11.
- Rao S, Rao S, Harvey HB, et al. Low back pain in the emergency department—are the ACR Appropriateness Criteria being followed? J Am Coll Radiol 2015;12:364–9.
- Drazin D, Nuño M, Patil CG, et al. Emergency room resource utilisation by patients with low-back pain. J Neurosurg Spine 2016;24:686–93.
- Borczuk P. An evidence-based approach to the evaluation and treatment of low back pain in the emergency department. Emerg Med Pract 2013;15:1–23. Quiz 23-4.
- Ficha técnica del medicamento Palexia retard [Summary of product characteristics for Palexia retard]. Agencia Española de Medicamentos y Productos Sanitarios [Spanish Agency of Medicines and Medical Devices].